Acne News

Healio has compiled March’s most-read news in dermatology.

Utilizing alternative, botanical treatments for acne may target the underlying causes of disease and improve severity, according to a study.

Fixed-dose clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% gel achieved faster-acting efficacy than dyads and vehicle, according to a study.

SAN DIEGO — Acne is common, iatrogenic and impactful to gender-diverse patients receiving gender-affirming care such as testosterone and should not be treated as a “transient rite of passage,” according to a speaker here.

SAN DIEGO — In this video perspective, Menas Kizoulis, senior director of global scientific engagement at Kenvue, discusses the company’s latest research presented at the American Academy of Dermatology Annual Meeting.

Acne products containing benzoyl peroxide developed high levels of benzene, a potentially cancer-causing chemical, when handled or stored at higher temperatures, according to a report from the independent laboratory Valisure.

Using the number needed to treat approach, researchers found that fixed-dose, triple-combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel had the most favorable efficacy rating, according to a study.

MIAMI BEACH, Fla. — Addressing the internal hormonal changes in women will directly affect the appearance of their skin, according to a speaker at South Beach Symposium.

The American Academy of Dermatology has released new care guidelines for acne vulgaris, according to a press release.

In addition to cutting edge content, the 22nd annual South Beach Symposium has added a “unique session” that focuses on how the medical and cosmetic dermatologist can work together to holistically treat patients.